Literature DB >> 9570337

Distribution and characterization of anandamide amidohydrolase in mouse brain and liver.

K Watanabe1, H Ogi, S Nakamura, Y Kayano, T Matsunaga, H Yoshimura, I Yamamoto.   

Abstract

Anandamide (N-Arachidonoylethanolamine) amidohydrolase catalyzing hydrolysis of anandamide was characterized in mice. The enzymatic activity was highest in the liver, followed by the brain and testis. Negligible activity was found in heart, lung and spleen. The activity in brain and liver was mainly localized in the microsomal fractions. Kinetic experiments demonstrated that Km (microM) and Vmax (nmol/min/mg protein) for the brain microsomes were 9.3 and 2.58, respectively, while those for the hepatic microsomes were 180 and 18.9, respectively. The activity in the microsomes from the liver and brain was markedly inhibited by Cu2+, Hg2+, Se4+, phenylmethylsulfonylfluoride and sodium dodecylsulfate. Brain but not hepatic microsomal enzyme activity was inhibited by delta9-tetrahydrocannabinol, cannabidiol and cannabinol. Kinetic parameters demonstrated that the inhibition by the cannabinoids was competitive in nature. Relatively high distribution of the enzyme activity in brain suggests an importance of the enzyme in the central nervous system to regulate the neuromodulatory fatty-acid amides.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9570337     DOI: 10.1016/s0024-3205(98)00052-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.

Authors:  Luciano De Petrocellis; Alessia Ligresti; Aniello Schiano Moriello; Marco Allarà; Tiziana Bisogno; Stefania Petrosino; Colin G Stott; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

2.  The 'specific' tyrosine kinase inhibitor genistein inhibits the enzymic hydrolysis of anandamide: implications for anandamide uptake.

Authors:  L Thors; K Alajakku; C J Fowler
Journal:  Br J Pharmacol       Date:  2007-02-26       Impact factor: 8.739

Review 3.  The current understanding of the benefits, safety, and regulation of cannabidiol in consumer products.

Authors:  Jinpeng Li; Ricardo Carvajal; Leon Bruner; Norbert E Kaminski
Journal:  Food Chem Toxicol       Date:  2021-10-06       Impact factor: 5.572

4.  Anandamide metabolism by fatty acid amide hydrolase in intact C6 glioma cells. Increased sensitivity to inhibition by ibuprofen and flurbiprofen upon reduction of extra- but not intracellular pH.

Authors:  Sandra Holt; Christopher J Fowler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-20       Impact factor: 3.000

5.  Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors.

Authors:  T V Zanelati; C Biojone; F A Moreira; F S Guimarães; Sâmia R L Joca
Journal:  Br J Pharmacol       Date:  2009-12-04       Impact factor: 8.739

6.  5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats.

Authors:  Leonardo B M Resstel; Rodrigo F Tavares; Sabrina F S Lisboa; Sâmia R L Joca; Fernando M A Corrêa; Francisco S Guimarães
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

7.  Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice.

Authors:  R Capasso; F Borrelli; G Aviello; B Romano; C Scalisi; F Capasso; A A Izzo
Journal:  Br J Pharmacol       Date:  2008-05-12       Impact factor: 8.739

8.  Synthesis and Preliminary PET Imaging Studies of a FAAH Radiotracer ([¹¹C]MPPO) Based on α-Ketoheterocyclic Scaffold.

Authors:  Lu Wang; Joji Yui; Qifan Wang; Yiding Zhang; Wakana Mori; Yoko Shimoda; Masayuki Fujinaga; Katsushi Kumata; Tomoteru Yamasaki; Akiko Hatori; Benjamin H Rotstein; Thomas Lee Collier; Chongzhao Ran; Neil Vasdev; Ming-Rong Zhang; Steven H Liang
Journal:  ACS Chem Neurosci       Date:  2015-11-17       Impact factor: 4.418

9.  Evidence against the presence of an anandamide transporter.

Authors:  Sherrye T Glaser; Nada A Abumrad; Folayan Fatade; Martin Kaczocha; Keith M Studholme; Dale G Deutsch
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

10.  TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons.

Authors:  Ning Qin; Michael P Neeper; Yi Liu; Tasha L Hutchinson; Mary Lou Lubin; Christopher M Flores
Journal:  J Neurosci       Date:  2008-06-11       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.